[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Linden posts on X about $abcl, $xbi, $18b, let him the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks technology brands finance
Social topic influence $abcl #14, $xbi, $18b, let him, university of, future of, vibe, market cap, $rxrx, $nvda
Top assets mentioned Bitcoin Incognito (XBI) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) NVIDIA Corp. (NVDA) Eli Lilly and Company (LLY) AbbVie Inc (ABBV) Gilead Sciences, Inc. (GILD)
Top posts by engagements in the last XX hours
"If anyone has a connection with Carl Hansen CEO of $ABCL let him know wed love to see him on X sharing his thoughts on the company their technology the future of AI in drug discovery and anything else worth hearing. His University of Austin speech was awesome"
X Link @iHooghvorst 2025-08-20T20:00Z 3318 followers, 6655 engagements
"@OdedRechavi Thanks mate. I am just scared of the vibe coding 🤣"
X Link @iHooghvorst 2025-10-16T08:15Z 3316 followers, XXX engagements
"Carl Hansen vision for Canadas health sector $ABCL. Great read. Thanks @Algo_Stoney for finding it"
X Link @iHooghvorst 2025-09-02T14:21Z 3318 followers, 10.8K engagements
"The defense would greatly appreciate a second expert opinion from none other than Mr. @MartinShkreli on $ABCL"
X Link @iHooghvorst 2025-10-02T14:32Z 3319 followers, 7347 engagements
"$RXRX will probably pump like crazy in the coming weeks from fund rotation into biotech and their AI-narrative. $RXRX looks promising since its backed by $NVDA but at the same time what does Nvidia really know about molecules and biotech They want to sell their product and see if new boundaries can be breached. Id be wary that the OS they claim to have developed and are using for small molecule development is not validated. Im skeptical about what kind of data theyve trained their models on. Small molecule discovery is pretty random finding engagement between a chemical compound and a target"
X Link @iHooghvorst 2025-10-06T10:16Z 3319 followers, 2082 engagements
"$ABCL closes above $X and $XBI above $100"
X Link @iHooghvorst 2025-09-30T20:43Z 3319 followers, 5270 engagements
"$ABCL is entering a double-front war at a $1.8B valuation where pumpers get excited about the price action and biotech investors are thinking about shorting it. I dont agree with any of those with the 'aBcL iS thE NeXt pAlanTir' nor the 'aBcL iS a fAilEd bioTecH' narratives. My thesis and @JackPrescottX about AbCelleras isnt getting much discussion and as Ive said before and want to state again: AbCellera is overvalued from a clinical drug standpoint. The two molecules in Phase I do NOT justify its current valuation at all. However we might be missing some information at this point of"
X Link @iHooghvorst 2025-10-09T10:06Z 3318 followers, 11.8K engagements
"@Jare92365776 Good finding 🫶. Its good to see progress on different partnerships through different routes papers published with gilead eli Lilly continuation abbvie new collab on tce spce and now this w vikings"
X Link @iHooghvorst 2025-10-13T06:09Z 3316 followers, XXX engagements
"If you started following me in the last 24h due to the $ABCL surge know this: AbCellera is an ambitious biotech company developing drugs and partnering with big companies for drug discovery and/or drug development. It is still in the early stages and without full validation of its platform. The stock has been extremely volatile from $XX to $XX on the first day of IPO all the way down to $X five months ago. Now we sit at $X. Most of biotech Twitter dislikes it due to: excessive retail hype lack of meaningful molecules in the clinic and lack of substantial revenues. Baker Brothers (legendary"
X Link @iHooghvorst 2025-10-02T11:47Z 3317 followers, 80.6K engagements
"This is the perfect example of $ABCL microfluidic use-case and superiority for hard antibody discovery. @JackPrescottX sent me this research paper published on Sept 2025 from $GILD where $ABCL did the antibody discovery using their microfluidic. The paper describes a new Tcell engager to target hepatitits B-infected cells. This results are still early stages of discovery but very significant to understand/validate (again) AbCellera's moat. I am putting together a small article explaining the important details"
X Link @iHooghvorst 2025-10-01T09:56Z 3316 followers, 34.5K engagements
"Glad you asked. As I said not everything is wrong but I do not agree on what you are doing here. Throwing lines such as: 'I believe $ABCL is positioned to become the platform that cures any physiological human illness'; or 'If the trials succeed $ABCL is going to become the machine that simply eliminates illness.' are grandiose sentences that prey on peoples hopes. I am extremely bullish on $ABCL but these lines are pure deception imo. Also every molecule is different and deserves a whole more attention than 'These molecules have massive end applications beyond the ones they are being trialed"
X Link @iHooghvorst 2025-10-01T19:38Z 3319 followers, 3093 engagements